This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: The Innovative Contributions of Periyasamy Selvam
Introduction
Periyasamy Selvam is a notable inventor based in Kerala, India. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds. His work focuses on the inhibition of specific enzymes that play a crucial role in cancer progression.
Latest Patents
Periyasamy Selvam holds a patent for "Fluoroquinolone derivatives or sulfonamide moiety-containing compounds as inhibitors of tyrosyl-DNA-phosphodiesterase (TDP1)." This patent outlines a method for treating cancer by administering a therapeutically effective amount of either a fluoroquinolone derivative or a sulfonamide moiety-containing compound that inhibits TDP1 activity. The method aims to effectively treat cancer in subjects by targeting the enzyme responsible for DNA repair, thereby enhancing the efficacy of cancer therapies.
Career Highlights
Throughout his career, Selvam has focused on developing innovative solutions for complex medical challenges. His research has led to advancements in cancer treatment methodologies, showcasing his commitment to improving patient outcomes. With a patent portfolio that includes one significant patent, he continues to contribute to the scientific community.
Collaborations
Periyasamy Selvam has collaborated with esteemed colleagues such as Yves Pommier and Christophe Marchand. These collaborations have enriched his research and expanded the impact of his work in the field of cancer treatment.
Conclusion
Periyasamy Selvam's innovative contributions to cancer treatment through his patented research exemplify the importance of scientific advancement in medicine. His work not only highlights his expertise but also underscores the potential for new therapies in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile